Impact of NEOD001 on Neuropathy in Patients With Light Chain Amyloidosis and Persistent Organ Dysfunction: Results From the Expansion Phase of a Phase 1/2 Study

被引：0

作者：

Liedtke, Michaela ^{[1
]}

Comenzo, Raymond L. ^{[2
]}

Landau, Heather ^{[3
]}

Sanchorawala, Vaishali ^{[4
]}

Weiss, Brendan M. ^{[5
]}

Zonder, Jeffrey ^{[6
]}

Walling, Jackie ^{[7
]}

Kinney, Gene G. ^{[8
]}

Koller, Martin ^{[8
]}

Schenk, Dale B. ^{[8
]}

Guthrie, Spencer D. ^{[8
]}

Liu, Enchi ^{[8
]}

Gertz, Morie A. ^{[9
]}

机构：

[1] Stanford Univ, Sch Med, Stanford, CA 94305 USA

[2] Tufts Med Ctr, Boston, MA 02111 USA

[3] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

[4] Boston Univ, Sch Med, Boston, MA 02118 USA

[5] Univ Penn, Philadelphia, PA 19104 USA

[6] Karmanos Canc Inst, Detroit, MI USA

[7] JW Consulting, Hillsborough, CA USA

[8] Prothena Biosci Inc, San Francisco, CA USA

[9] Mayo Clin, Rochester, MN USA

来源：

NEUROLOGY | 2017年 / 88卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

S5.001

引用

页数：3

共 50 条

[41] MLN9708, a Novel, Investigational Oral Proteasome Inhibitor, in Patients with Relapsed or Refractory Light-Chain Amyloidosis (AL): Results of a Phase 1 Study
Merlini, Giampaolo
Sanchorawala, Vaishali
Zonder, Jeffrey A.
Kukreti, Vishal
Schonland, Stefan O.
Jaccard, Arnaud
Dispenzieri, Angela
Cohen, Adam D.
Berg, Deborah
Liu, Guohui
Di Bacco, Alessandra
Gupta, Neeraj
Hui, Ai-Min
Palladini, Giovanni
Comenzo, Raymond L.
BLOOD, 2012, 120 (21)
[42] Acalabrutinib Monotherapy in Patients with Ibrutinib Intolerance: Results from the Phase 1/2 ACE-CL-001 Clinical Study
Awan, Farrukh T.
Schuh, Anna
Brown, Jennifer R.
Furman, Richard R.
Pagel, John M.
Hillmen, Peter
Stephens, Deborah M.
Hamdy, Ahmed
Huang, Jane
Izumi, Raquel
Patel, Priti
Wang, Min Hui
Byrd, John C.
BLOOD, 2016, 128 (22)
[43] Acalabrutinib Monotherapy in Patients With Ibrutinib Intolerance: Results From the Phase 1/2 ACE-CL-001 Clinical Study
不详
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2016, 14 (12) : 14 - 16
[44] Lenalidomide/melphalan/dexamethasone in newly diagnosed patients with immunoglobulin light chain amyloidosis: results of a prospective phase 2 study with long-term follow up
Hegenbart, Ute
Bochtler, Tilmann
Benner, Axel
Becker, Natalia
Kimmich, Christoph
Kristen, Arnt V.
Beimler, Jorg
Hund, Ernst
Zorn, Markus
Freiberger, Anja
Gawlik, Marianne
Goldschmidt, Hartmut
Hose, Dirk
Jauch, Anna
Ho, Anthony D.
Schoenland, Stefan O.
HAEMATOLOGICA, 2017, 102 (08) : 1424 - 1431
[45] Updated Results of a Phase 2 Study of Bendamustine in Combination with Dexamethasone (Ben/Dex) in Patients with Previously-Treated Systemic Light-Chain (AL) Amyloidosis
Lentzsch, Suzanne
Comenzo, Raymond L.
Zonder, Jeffrey A.
Osman, Keren
Susanna, Miao
Backenroth, Daniel
Otap, Daniel
Tsai, Wei-Yann
Pregja, Siva
Raza, Shahzad
Sanchorawala, Vaishali
Landau, Heather J.
BLOOD, 2015, 126 (23)
[46] Lenalidomide/Melphalan / Dexamethasone Chemotherapy In 50 Patients With Newly Diagnosed Amyloid Light Chain Amyloidosis: First Results Of a Prospective Single Center Phase 2 Study (Leomex)
Schonland, Stefan O.
Bochtler, Tilmann
Benner, Axel
Gawlik, Marianne
Kimmich, Christoph
Kristen, Arnt V.
Beimler, Joerg
Ho, Anthony D.
Hegenbart, Ute
BLOOD, 2013, 122 (21)
[47] Phase 2 Study of Bendamustine in Combination with Dexamethasone (Ben/Dex) in Patients with Previously-Treated Systemic Light Chain (AL) Amyloidosis
Lentzsch, Suzanne
Comenzo, Raymond L.
Osman, Keren
Zikaras, Kevin
Backenroth, Daniel
Tsai, Wei-Yann
Sanchorawala, Vaishali
Landau, Heather
BLOOD, 2014, 124 (21)
[48] Efficacy and Safety of Belantamab Mafodotin Monotherapy in Patients with Relapsed or Refractory Light Chain Amyloidosis: A Phase 2 Study By the European Myeloma Network
Kastritis, Efstathios
Palladini, Giovanni
Dimopoulos, Meletios Athanasios
Jaccard, Arnaud
Merlini, Giampaolo
Theodorakakou, Foteini
Fotiou, Despina
Minnema, Monique C.
Wechalekar, Ashutosh D.
Papachristou, Elena
Psarros, Giorgos
Sonneveld, Pieter
Schonland, Stefan
BLOOD, 2023, 142
[49] Efficacy and safety of belantamab mafodotin monotherapy in patients with relapsed or refractory light chain amyloidosis: a phase 2 study by the European Myeloma Network
Kastritis, Efstathios
Palladini, Giovanni
Dimopoulos, Meletios A.
Jaccard, Arnaud
Merlini, Giampaolo
Theodorakakou, Foteini
Fotiou, Despina
Minnema, Monique C.
Wechalekar, Ashutosh
Ninos, Ioannis
Psarros, Giorgos
Sonneveld, Pieter
Schoenland, Stefan
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2024, 31 : S72 - S73
[50] Efficacy and Safety of Belantamab Mafodotin Monotherapy in Patients with Relapsed or Refractory Light Chain Amyloidosis: A Phase 2 Study By the European Myeloma Network
Kastritis, Efstathios
Palladini, Giovanni
Dimopoulos, Meletios-Athanasios
Jaccard, Arnaud
Merlini, Giampaolo
Theodorakakou, Foteini
Fotiou, Despina
Minnema, Monique C.
Wechalekar, Ashutosh D.
Varghese, Sreeja
Manousou, Kyriaki
Sonneveld, Pieter
Schoenland, Stefan
BLOOD, 2022, 140 : 7294 - 7296

← 1 2 3 4 5 →